News & media
-
Zealand Pharma to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13th
-
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
-
Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.
-
U.S. Food and Drug Administration issues Complete Response Letter for the glepaglutide New Drug Application for the treatment of short bowel syndrome
-
Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesity
-
Zealand Pharma to participate in the Jefferies London Healthcare Conference
-
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
-
Zealand Pharma Announces Financial Results for the First Nine Months of 2024
-
Zealand Pharma conference call on November 7 at 2pm CET (8am ET) to present third quarter 2024 financial results
-
Zealand Pharma provides U.S. regulatory update on dasiglucagon in congenital hyperinsulinism
-
Zealand Pharma announces that Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two Phase III trials in MASH for survodutide
-
Total number of shares and voting rights in Zealand Pharma A/S on September 30, 2024
Corporate management
-
Adam Steensberg - President and Chief Executive Officer
-
Adam Steensberg - President and Chief Executive Officer
-
Adam Steensberg - President and Chief Executive Officer
-
Henriette Wennicke - Executive Vice President and Chief Financial Officer
-
Christina Sonnenborg Bredal - Executive Vice President and Chief People Officer
-
David Kendall - Executive Vice President, Research & Development and Chief Medical Officer
-
Ivan Møller - Executive Vice President and Chief Operating Officer
-
Utpal Singh - Executive Vice President and Chief Scientific Officer
-
Utpal Singh - Executive Vice President and Chief Scientific Officer
-
Steven Johnson - Executive Vice President, Chief Development Officer
-
Eric Cox - Executive Vice President, Chief Commercial Officer
Research and development
-
Lab photo
-
Lab photo
-
Lab photo
-
Lab photo
-
Lab photo
-
Lab photo
-
Lab photo
Sustainability
-
Morten Lagstrøm - ESG Officer
Logos and icons
-
)
Zealand Pharma Logo (RGB)
Stay up-to-date with the latest news from Zealand
Sign-up to receive press releases and company announcements directly to your inbox
Investor and Media contacts
